DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Organ Transplant Diagnostics Market 2021-2031 by Offering, Transplant, Application, Technology, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific organ transplant diagnostics market will grow by 10.8% annually with a total addressable market cap of $12,042.8 million over 2022-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Test Kits & Consumables
• Kits & Assays
• Consumables
• Software & Services

Based on Transplant, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Solid Organ Transplant
• Kidney
• Liver
• Heart
• Lung
• Pancreas
• Kidney-Pancreas
• Other Solid Organ Transplants
• Stem Cell Transplant
• Soft Tissue Transplant

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Diagnostics
• Donor Testing
• Recipient Testing
• Translational Research

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Molecular Technologies
• PCR
• Sequencing
• Other Molecular Technologies
• Serology
• Flow Cytometry
• Other Technologies

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospitals and Transplant Centers
• Reference Laboratories
• Academic and Research Institutions
• Other End Users

Selected Key Players

• Abbott Laboratories Inc.
• ARUP Laboratories
• BAG Health Care GmbH
• Becton Dickinson and Company
• bioMerieux S.A.
• Bio-Rad Laboratories, Inc.
• CareDx, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Immucor, Inc.
• Laboratory Corporation of America Holdings
• Novacyt Group
• Omixon Ltd.
• OPKO Health
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Asia Pacific Market by Offering

4 Segmentation of Asia Pacific Market by Transplant

5 Segmentation of Asia Pacific Market by Application

6 Segmentation of Asia Pacific Market by Technology

7 Segmentation of Asia Pacific Market by End User

8 Asia-Pacific Market 2021-2031 by Country

Companies Mentioned

• Abbott Laboratories Inc.
• ARUP Laboratories
• BAG Health Care GmbH
• Becton Dickinson and Company
• bioMerieux S.A.
• Bio-Rad Laboratories, Inc.
• CareDx, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Immucor, Inc.
• Laboratory Corporation of America Holdings
• Novacyt Group
• Omixon Ltd.
• OPKO Health
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/pkt63l

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900